Covered recipient · General Payments record
ALEXANDER EVAN CASHMAN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2022–2024
$1,944.04
- Reported across 89 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $429.26 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $102.36 | 6 |
| Corium, Inc. | $98.33 | 8 |
| Neurocrine BioSciences, Inc. | $76.44 | 3 |
| Lundbeck LLC | $71.94 | 4 |
| Alkermes, Inc. | $29.10 | 1 |
| Vanda Pharmaceuticals Inc. | $17.45 | 1 |
| BioXcel Therapeutics, Inc. | $17.05 | 1 |
| Teva Pharmaceuticals USA, Inc. | $16.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.27 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103425787 | CMS |
| ABBVIE INC. | $14.23 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103425789 | CMS |
| ABBVIE INC. | $14.93 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103425791 | CMS |
| ABBVIE INC. | $18.65 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103425793 | CMS |
| ABBVIE INC. | $13.49 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103425795 | CMS |
| ABBVIE INC. | $18.79 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103425797 | CMS |
| Alkermes, Inc. | $29.10 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120477020 | CMS |
| BioXcel Therapeutics, Inc. | $17.05 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150028704 | CMS |
| Corium, LLC | $16.23 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100109464 | CMS |
| Corium, LLC | $16.17 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100109772 | CMS |
| Corium, LLC | $1.58 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100136999 | CMS |
| Corium, LLC | $20.44 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100096215 | CMS |
| Corium, LLC | $20.21 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100097011 | CMS |
| Corium, LLC | $2.24 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100141735 | CMS |
| Corium, LLC | $19.39 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100216769 | CMS |
| Corium, LLC | $2.07 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100216775 | CMS |
| Lundbeck LLC | $17.40 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145903246 | CMS |
| Lundbeck LLC | $21.12 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145903248 | CMS |
| Lundbeck LLC | $14.63 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145903250 | CMS |
| Lundbeck LLC | $18.79 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145903252 | CMS |
| Neurocrine Biosciences, Inc. | $22.41 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150849728 | CMS |
| Neurocrine Biosciences, Inc. | $28.65 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150829174 | CMS |
| Neurocrine Biosciences, Inc. | $25.38 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150838822 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.59 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151644399 | CMS |
| Vanda Pharmaceuticals Inc. | $17.45 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133898907 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.